BIOMAT Database Logo BIOMAT Database Logo

Cytostatic antibody and SV40 tumour immunity in hamsters. 1971

K R Ambrose, and N G Anderson, and J H Coggin

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013539 Simian virus 40 A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures. SV40 Virus,Vacuolating Agent,Polyomavirus macacae,SV 40 Virus,SV 40 Viruses,SV40 Viruses,Vacuolating Agents

Related Publications

K R Ambrose, and N G Anderson, and J H Coggin
Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers.
October 1974, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
K R Ambrose, and N G Anderson, and J H Coggin
On concomitant immunity in tumour-bearing hamsters.
February 1967, Nature,
K R Ambrose, and N G Anderson, and J H Coggin
A rapid in vivo assay for SV40 tumor immunity in hamsters.
January 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K R Ambrose, and N G Anderson, and J H Coggin
Induction of specific antitumor immunity in hamsters with hydroxylamine-inactivated SV40 virus.
December 1966, Virology,
K R Ambrose, and N G Anderson, and J H Coggin
Failure to induce transplantation immunity to an SV40-induced tumour in hamsters immunized with basic proteins of myelin or malignant tissues.
July 1978, British journal of cancer,
K R Ambrose, and N G Anderson, and J H Coggin
Renal deposition of soluble immune complexes in hamsters bearing an SV40-induced tumour.
January 1978, Annales d'immunologie,
K R Ambrose, and N G Anderson, and J H Coggin
CORRELATION BETWEEN COMPLEMENT-FIXING CELL ANTIBODY AND IMMUNOFLUORESCENT NUCLEAR ANTIBODY IN HAMSTERS BEARING 'SV40'-INDUCED TUMORS.
February 1965, Nature,
K R Ambrose, and N G Anderson, and J H Coggin
Specific simian virus 40 (SV40)-induced immunity against transplantable SV40 tumor in Syrian hamsters: abrogation by BCG vaccination.
April 1977, Journal of the National Cancer Institute,
K R Ambrose, and N G Anderson, and J H Coggin
SV40 induces mesotheliomas in hamsters.
May 1993, The American journal of pathology,
K R Ambrose, and N G Anderson, and J H Coggin
Humoral and cellular immune response during the growth of an SV40 induced tumour in hamsters.
October 1977, Annales de microbiologie,
Copied contents to your clipboard!